【市場調査レポート】液体塞栓剤のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Liquid Embolic Agent Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。液体塞栓剤のグローバル市場インサイト・予測（～2028年） / Global Liquid Embolic Agent Market Insights, Forecast to 2028 / QY2207E09663資料のイメージです。

• レポートコード：QY2207E09663
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の液体塞栓剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に液体塞栓剤の世界市場のxxx％を占める「6％EVOH」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「動静脈奇形」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の液体塞栓剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの液体塞栓剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの液体塞栓剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

液体塞栓剤のグローバル主要メーカーには、Medtronic、Terumo、Balt、MicroVention、CERENOVUS、Meril Life、Saikesaisi Holdingなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

液体塞栓剤市場は、種類と用途によって区分されます。世界の液体塞栓剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
6％EVOH、8％EVOH

【用途別セグメント】
動静脈奇形、血管過多腫瘍、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 液体塞栓剤製品概要
- 種類別市場（6％EVOH、8％EVOH）
- 用途別市場（動静脈奇形、血管過多腫瘍、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の液体塞栓剤販売量予測2017-2028
- 世界の液体塞栓剤売上予測2017-2028
- 液体塞栓剤の地域別販売量
- 液体塞栓剤の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別液体塞栓剤販売量
- 主要メーカー別液体塞栓剤売上
- 主要メーカー別液体塞栓剤価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（6％EVOH、8％EVOH）
- 液体塞栓剤の種類別販売量
- 液体塞栓剤の種類別売上
- 液体塞栓剤の種類別価格
・用途別市場規模（動静脈奇形、血管過多腫瘍、その他）
- 液体塞栓剤の用途別販売量
- 液体塞栓剤の用途別売上
- 液体塞栓剤の用途別価格
・北米市場
- 北米の液体塞栓剤市場規模（種類別、用途別）
- 主要国別の液体塞栓剤市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの液体塞栓剤市場規模（種類別、用途別）
- 主要国別の液体塞栓剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の液体塞栓剤市場規模（種類別、用途別）
- 主要国別の液体塞栓剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の液体塞栓剤市場規模（種類別、用途別）
- 主要国別の液体塞栓剤市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの液体塞栓剤市場規模（種類別、用途別）
- 主要国別の液体塞栓剤市場規模（トルコ、サウジアラビア）
・企業情報
Medtronic、Terumo、Balt、MicroVention、CERENOVUS、Meril Life、Saikesaisi Holding
・産業チェーン及び販売チャネル分析
- 液体塞栓剤の産業チェーン分析
- 液体塞栓剤の原材料
- 液体塞栓剤の生産プロセス
- 液体塞栓剤の販売及びマーケティング
- 液体塞栓剤の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 液体塞栓剤の産業動向
- 液体塞栓剤のマーケットドライバー
- 液体塞栓剤の課題
- 液体塞栓剤の阻害要因
・主な調査結果

Market Analysis and Insights: Global Liquid Embolic Agent Market
Due to the COVID-19 pandemic, the global Liquid Embolic Agent market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 6% EVOH accounting for % of the Liquid Embolic Agent global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Arteriovenous Malformations segment is altered to an % CAGR throughout this forecast period.
China Liquid Embolic Agent market size is valued at US$ million in 2021, while the US and Europe Liquid Embolic Agent are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Liquid Embolic Agent landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Liquid Embolic Agent include Medtronic, Terumo, Balt, MicroVention, CERENOVUS, Meril Life and Saikesaisi Holding, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Liquid Embolic Agent Scope and Segment
Liquid Embolic Agent market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Liquid Embolic Agent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
6% EVOH
8% EVOH
Segment by Application
Arteriovenous Malformations
Hypervascular Tumors
Other
By Company
Medtronic
Terumo
Balt
MicroVention
CERENOVUS
Meril Life
Saikesaisi Holding
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Liquid Embolic Agent Product Introduction
1.2 Market by Type
1.2.1 Global Liquid Embolic Agent Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 6% EVOH
1.2.3 8% EVOH
1.3 Market by Application
1.3.1 Global Liquid Embolic Agent Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Arteriovenous Malformations
1.3.3 Hypervascular Tumors
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liquid Embolic Agent Sales Estimates and Forecasts 2017-2028
2.2 Global Liquid Embolic Agent Revenue Estimates and Forecasts 2017-2028
2.3 Global Liquid Embolic Agent Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Liquid Embolic Agent Sales by Region
2.4.1 Global Liquid Embolic Agent Sales by Region (2017-2022)
2.4.2 Global Sales Liquid Embolic Agent by Region (2023-2028)
2.5 Global Liquid Embolic Agent Revenue by Region
2.5.1 Global Liquid Embolic Agent Revenue by Region (2017-2022)
2.5.2 Global Liquid Embolic Agent Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Liquid Embolic Agent Sales by Manufacturers
3.1.1 Global Top Liquid Embolic Agent Manufacturers by Sales (2017-2022)
3.1.2 Global Liquid Embolic Agent Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Liquid Embolic Agent in 2021
3.2 Global Liquid Embolic Agent Revenue by Manufacturers
3.2.1 Global Liquid Embolic Agent Revenue by Manufacturers (2017-2022)
3.2.2 Global Liquid Embolic Agent Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Liquid Embolic Agent Revenue in 2021
3.3 Global Liquid Embolic Agent Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Liquid Embolic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Liquid Embolic Agent Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Liquid Embolic Agent Sales by Type
4.1.1 Global Liquid Embolic Agent Historical Sales by Type (2017-2022)
4.1.2 Global Liquid Embolic Agent Forecasted Sales by Type (2023-2028)
4.1.3 Global Liquid Embolic Agent Sales Market Share by Type (2017-2028)
4.2 Global Liquid Embolic Agent Revenue by Type
4.2.1 Global Liquid Embolic Agent Historical Revenue by Type (2017-2022)
4.2.2 Global Liquid Embolic Agent Forecasted Revenue by Type (2023-2028)
4.2.3 Global Liquid Embolic Agent Revenue Market Share by Type (2017-2028)
4.3 Global Liquid Embolic Agent Price by Type
4.3.1 Global Liquid Embolic Agent Price by Type (2017-2022)
4.3.2 Global Liquid Embolic Agent Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Liquid Embolic Agent Sales by Application
5.1.1 Global Liquid Embolic Agent Historical Sales by Application (2017-2022)
5.1.2 Global Liquid Embolic Agent Forecasted Sales by Application (2023-2028)
5.1.3 Global Liquid Embolic Agent Sales Market Share by Application (2017-2028)
5.2 Global Liquid Embolic Agent Revenue by Application
5.2.1 Global Liquid Embolic Agent Historical Revenue by Application (2017-2022)
5.2.2 Global Liquid Embolic Agent Forecasted Revenue by Application (2023-2028)
5.2.3 Global Liquid Embolic Agent Revenue Market Share by Application (2017-2028)
5.3 Global Liquid Embolic Agent Price by Application
5.3.1 Global Liquid Embolic Agent Price by Application (2017-2022)
5.3.2 Global Liquid Embolic Agent Price Forecast by Application (2023-2028)
6 North America
6.1 North America Liquid Embolic Agent Market Size by Type
6.1.1 North America Liquid Embolic Agent Sales by Type (2017-2028)
6.1.2 North America Liquid Embolic Agent Revenue by Type (2017-2028)
6.2 North America Liquid Embolic Agent Market Size by Application
6.2.1 North America Liquid Embolic Agent Sales by Application (2017-2028)
6.2.2 North America Liquid Embolic Agent Revenue by Application (2017-2028)
6.3 North America Liquid Embolic Agent Market Size by Country
6.3.1 North America Liquid Embolic Agent Sales by Country (2017-2028)
6.3.2 North America Liquid Embolic Agent Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Liquid Embolic Agent Market Size by Type
7.1.1 Europe Liquid Embolic Agent Sales by Type (2017-2028)
7.1.2 Europe Liquid Embolic Agent Revenue by Type (2017-2028)
7.2 Europe Liquid Embolic Agent Market Size by Application
7.2.1 Europe Liquid Embolic Agent Sales by Application (2017-2028)
7.2.2 Europe Liquid Embolic Agent Revenue by Application (2017-2028)
7.3 Europe Liquid Embolic Agent Market Size by Country
7.3.1 Europe Liquid Embolic Agent Sales by Country (2017-2028)
7.3.2 Europe Liquid Embolic Agent Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Liquid Embolic Agent Market Size by Type
8.1.1 Asia Pacific Liquid Embolic Agent Sales by Type (2017-2028)
8.1.2 Asia Pacific Liquid Embolic Agent Revenue by Type (2017-2028)
8.2 Asia Pacific Liquid Embolic Agent Market Size by Application
8.2.1 Asia Pacific Liquid Embolic Agent Sales by Application (2017-2028)
8.2.2 Asia Pacific Liquid Embolic Agent Revenue by Application (2017-2028)
8.3 Asia Pacific Liquid Embolic Agent Market Size by Region
8.3.1 Asia Pacific Liquid Embolic Agent Sales by Region (2017-2028)
8.3.2 Asia Pacific Liquid Embolic Agent Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Liquid Embolic Agent Market Size by Type
9.1.1 Latin America Liquid Embolic Agent Sales by Type (2017-2028)
9.1.2 Latin America Liquid Embolic Agent Revenue by Type (2017-2028)
9.2 Latin America Liquid Embolic Agent Market Size by Application
9.2.1 Latin America Liquid Embolic Agent Sales by Application (2017-2028)
9.2.2 Latin America Liquid Embolic Agent Revenue by Application (2017-2028)
9.3 Latin America Liquid Embolic Agent Market Size by Country
9.3.1 Latin America Liquid Embolic Agent Sales by Country (2017-2028)
9.3.2 Latin America Liquid Embolic Agent Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Liquid Embolic Agent Market Size by Type
10.1.1 Middle East and Africa Liquid Embolic Agent Sales by Type (2017-2028)
10.1.2 Middle East and Africa Liquid Embolic Agent Revenue by Type (2017-2028)
10.2 Middle East and Africa Liquid Embolic Agent Market Size by Application
10.2.1 Middle East and Africa Liquid Embolic Agent Sales by Application (2017-2028)
10.2.2 Middle East and Africa Liquid Embolic Agent Revenue by Application (2017-2028)
10.3 Middle East and Africa Liquid Embolic Agent Market Size by Country
10.3.1 Middle East and Africa Liquid Embolic Agent Sales by Country (2017-2028)
10.3.2 Middle East and Africa Liquid Embolic Agent Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Liquid Embolic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Medtronic Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Recent Developments
11.2 Terumo
11.2.1 Terumo Corporation Information
11.2.2 Terumo Overview
11.2.3 Terumo Liquid Embolic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Terumo Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Terumo Recent Developments
11.3 Balt
11.3.1 Balt Corporation Information
11.3.2 Balt Overview
11.3.3 Balt Liquid Embolic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Balt Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Balt Recent Developments
11.4 MicroVention
11.4.1 MicroVention Corporation Information
11.4.2 MicroVention Overview
11.4.3 MicroVention Liquid Embolic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 MicroVention Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MicroVention Recent Developments
11.5 CERENOVUS
11.5.1 CERENOVUS Corporation Information
11.5.2 CERENOVUS Overview
11.5.3 CERENOVUS Liquid Embolic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CERENOVUS Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CERENOVUS Recent Developments
11.6 Meril Life
11.6.1 Meril Life Corporation Information
11.6.2 Meril Life Overview
11.6.3 Meril Life Liquid Embolic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Meril Life Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Meril Life Recent Developments
11.7 Saikesaisi Holding
11.7.1 Saikesaisi Holding Corporation Information
11.7.2 Saikesaisi Holding Overview
11.7.3 Saikesaisi Holding Liquid Embolic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Saikesaisi Holding Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Saikesaisi Holding Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Liquid Embolic Agent Industry Chain Analysis
12.2 Liquid Embolic Agent Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Liquid Embolic Agent Production Mode & Process
12.4 Liquid Embolic Agent Sales and Marketing
12.4.1 Liquid Embolic Agent Sales Channels
12.4.2 Liquid Embolic Agent Distributors
12.5 Liquid Embolic Agent Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Liquid Embolic Agent Industry Trends
13.2 Liquid Embolic Agent Market Drivers
13.3 Liquid Embolic Agent Market Challenges
13.4 Liquid Embolic Agent Market Restraints
14 Key Findings in The Global Liquid Embolic Agent Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Liquid Embolic Agent Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 6% EVOH
Table 3. Major Manufacturers of 8% EVOH
Table 4. Global Liquid Embolic Agent Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Liquid Embolic Agent Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Liquid Embolic Agent Sales by Region (2017-2022) & (K Units)
Table 7. Global Liquid Embolic Agent Sales Market Share by Region (2017-2022)
Table 8. Global Liquid Embolic Agent Sales by Region (2023-2028) & (K Units)
Table 9. Global Liquid Embolic Agent Sales Market Share by Region (2023-2028)
Table 10. Global Liquid Embolic Agent Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Liquid Embolic Agent Revenue Market Share by Region (2017-2022)
Table 12. Global Liquid Embolic Agent Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Liquid Embolic Agent Revenue Market Share by Region (2023-2028)
Table 14. Global Liquid Embolic Agent Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Liquid Embolic Agent Sales Share by Manufacturers (2017-2022)
Table 16. Global Liquid Embolic Agent Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Liquid Embolic Agent Revenue Share by Manufacturers (2017-2022)
Table 18. Liquid Embolic Agent Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Liquid Embolic Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Liquid Embolic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Embolic Agent as of 2021)
Table 21. Liquid Embolic Agent Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Liquid Embolic Agent Product Offered
Table 23. Date of Manufacturers Enter into Liquid Embolic Agent Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Liquid Embolic Agent Sales by Type (2017-2022) & (K Units)
Table 26. Global Liquid Embolic Agent Sales by Type (2023-2028) & (K Units)
Table 27. Global Liquid Embolic Agent Sales Share by Type (2017-2022)
Table 28. Global Liquid Embolic Agent Sales Share by Type (2023-2028)
Table 29. Global Liquid Embolic Agent Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Liquid Embolic Agent Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Liquid Embolic Agent Revenue Share by Type (2017-2022)
Table 32. Global Liquid Embolic Agent Revenue Share by Type (2023-2028)
Table 33. Liquid Embolic Agent Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Liquid Embolic Agent Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Liquid Embolic Agent Sales by Application (2017-2022) & (K Units)
Table 36. Global Liquid Embolic Agent Sales by Application (2023-2028) & (K Units)
Table 37. Global Liquid Embolic Agent Sales Share by Application (2017-2022)
Table 38. Global Liquid Embolic Agent Sales Share by Application (2023-2028)
Table 39. Global Liquid Embolic Agent Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Liquid Embolic Agent Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Liquid Embolic Agent Revenue Share by Application (2017-2022)
Table 42. Global Liquid Embolic Agent Revenue Share by Application (2023-2028)
Table 43. Liquid Embolic Agent Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Liquid Embolic Agent Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Liquid Embolic Agent Sales by Type (2017-2022) & (K Units)
Table 46. North America Liquid Embolic Agent Sales by Type (2023-2028) & (K Units)
Table 47. North America Liquid Embolic Agent Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Liquid Embolic Agent Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Liquid Embolic Agent Sales by Application (2017-2022) & (K Units)
Table 50. North America Liquid Embolic Agent Sales by Application (2023-2028) & (K Units)
Table 51. North America Liquid Embolic Agent Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Liquid Embolic Agent Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Liquid Embolic Agent Sales by Country (2017-2022) & (K Units)
Table 54. North America Liquid Embolic Agent Sales by Country (2023-2028) & (K Units)
Table 55. North America Liquid Embolic Agent Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Liquid Embolic Agent Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Liquid Embolic Agent Sales by Type (2017-2022) & (K Units)
Table 58. Europe Liquid Embolic Agent Sales by Type (2023-2028) & (K Units)
Table 59. Europe Liquid Embolic Agent Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Liquid Embolic Agent Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Liquid Embolic Agent Sales by Application (2017-2022) & (K Units)
Table 62. Europe Liquid Embolic Agent Sales by Application (2023-2028) & (K Units)
Table 63. Europe Liquid Embolic Agent Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Liquid Embolic Agent Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Liquid Embolic Agent Sales by Country (2017-2022) & (K Units)
Table 66. Europe Liquid Embolic Agent Sales by Country (2023-2028) & (K Units)
Table 67. Europe Liquid Embolic Agent Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Liquid Embolic Agent Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Liquid Embolic Agent Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Liquid Embolic Agent Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Liquid Embolic Agent Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Liquid Embolic Agent Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Liquid Embolic Agent Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Liquid Embolic Agent Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Liquid Embolic Agent Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Liquid Embolic Agent Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Liquid Embolic Agent Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Liquid Embolic Agent Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Liquid Embolic Agent Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Liquid Embolic Agent Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Liquid Embolic Agent Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Liquid Embolic Agent Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Liquid Embolic Agent Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Liquid Embolic Agent Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Liquid Embolic Agent Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Liquid Embolic Agent Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Liquid Embolic Agent Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Liquid Embolic Agent Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Liquid Embolic Agent Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Liquid Embolic Agent Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Liquid Embolic Agent Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Liquid Embolic Agent Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Liquid Embolic Agent Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Liquid Embolic Agent Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Liquid Embolic Agent Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Liquid Embolic Agent Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Liquid Embolic Agent Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Liquid Embolic Agent Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Liquid Embolic Agent Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Liquid Embolic Agent Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Liquid Embolic Agent Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Liquid Embolic Agent Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Liquid Embolic Agent Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Liquid Embolic Agent Revenue by Country (2023-2028) & (US$ Million)
Table 105. Medtronic Corporation Information
Table 106. Medtronic Description and Major Businesses
Table 107. Medtronic Liquid Embolic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Medtronic Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Medtronic Recent Developments
Table 110. Terumo Corporation Information
Table 111. Terumo Description and Major Businesses
Table 112. Terumo Liquid Embolic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Terumo Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Terumo Recent Developments
Table 115. Balt Corporation Information
Table 116. Balt Description and Major Businesses
Table 117. Balt Liquid Embolic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Balt Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Balt Recent Developments
Table 120. MicroVention Corporation Information
Table 121. MicroVention Description and Major Businesses
Table 122. MicroVention Liquid Embolic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. MicroVention Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. MicroVention Recent Developments
Table 125. CERENOVUS Corporation Information
Table 126. CERENOVUS Description and Major Businesses
Table 127. CERENOVUS Liquid Embolic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. CERENOVUS Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. CERENOVUS Recent Developments
Table 130. Meril Life Corporation Information
Table 131. Meril Life Description and Major Businesses
Table 132. Meril Life Liquid Embolic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Meril Life Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Meril Life Recent Developments
Table 135. Saikesaisi Holding Corporation Information
Table 136. Saikesaisi Holding Description and Major Businesses
Table 137. Saikesaisi Holding Liquid Embolic Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Saikesaisi Holding Liquid Embolic Agent Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Saikesaisi Holding Recent Developments
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Liquid Embolic Agent Distributors List
Table 143. Liquid Embolic Agent Customers List
Table 144. Liquid Embolic Agent Market Trends
Table 145. Liquid Embolic Agent Market Drivers
Table 146. Liquid Embolic Agent Market Challenges
Table 147. Liquid Embolic Agent Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Liquid Embolic Agent Product Picture
Figure 3. Global Liquid Embolic Agent Market Share by Type in 2021 & 2028
Figure 3. 6% EVOH Product Picture
Figure 4. 8% EVOH Product Picture
Figure 5. Global Liquid Embolic Agent Market Share by Application in 2021 & 2028
Figure 6. Arteriovenous Malformations
Figure 7. Hypervascular Tumors
Figure 8. Other
Figure 9. Liquid Embolic Agent Report Years Considered
Figure 10. Global Liquid Embolic Agent Sales 2017-2028 (K Units)
Figure 11. Global Liquid Embolic Agent Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Liquid Embolic Agent Revenue 2017-2028 (US$ Million)
Figure 13. Global Liquid Embolic Agent Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Liquid Embolic Agent Sales Market Share by Region (2017-2022)
Figure 15. Global Liquid Embolic Agent Sales Market Share by Region (2023-2028)
Figure 16. North America Liquid Embolic Agent Sales YoY (2017-2028) & (K Units)
Figure 17. North America Liquid Embolic Agent Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Liquid Embolic Agent Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Liquid Embolic Agent Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Liquid Embolic Agent Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Liquid Embolic Agent Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Liquid Embolic Agent Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Liquid Embolic Agent Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Liquid Embolic Agent Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Liquid Embolic Agent Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Liquid Embolic Agent Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Liquid Embolic Agent in the World: Market Share by Liquid Embolic Agent Revenue in 2021
Figure 28. Global Liquid Embolic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Liquid Embolic Agent Sales Market Share by Type (2017-2028)
Figure 30. Global Liquid Embolic Agent Revenue Market Share by Type (2017-2028)
Figure 31. Global Liquid Embolic Agent Sales Market Share by Application (2017-2028)
Figure 32. Global Liquid Embolic Agent Revenue Market Share by Application (2017-2028)
Figure 33. North America Liquid Embolic Agent Sales Market Share by Type (2017-2028)
Figure 34. North America Liquid Embolic Agent Revenue Market Share by Type (2017-2028)
Figure 35. North America Liquid Embolic Agent Sales Market Share by Application (2017-2028)
Figure 36. North America Liquid Embolic Agent Revenue Market Share by Application (2017-2028)
Figure 37. North America Liquid Embolic Agent Sales Share by Country (2017-2028)
Figure 38. North America Liquid Embolic Agent Revenue Share by Country (2017-2028)
Figure 39. United States Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Liquid Embolic Agent Sales Market Share by Type (2017-2028)
Figure 42. Europe Liquid Embolic Agent Revenue Market Share by Type (2017-2028)
Figure 43. Europe Liquid Embolic Agent Sales Market Share by Application (2017-2028)
Figure 44. Europe Liquid Embolic Agent Revenue Market Share by Application (2017-2028)
Figure 45. Europe Liquid Embolic Agent Sales Share by Country (2017-2028)
Figure 46. Europe Liquid Embolic Agent Revenue Share by Country (2017-2028)
Figure 47. Germany Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 48. France Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Liquid Embolic Agent Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Liquid Embolic Agent Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Liquid Embolic Agent Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Liquid Embolic Agent Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Liquid Embolic Agent Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Liquid Embolic Agent Revenue Share by Region (2017-2028)
Figure 58. China Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 61. India Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Liquid Embolic Agent Sales Market Share by Type (2017-2028)
Figure 68. Latin America Liquid Embolic Agent Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Liquid Embolic Agent Sales Market Share by Application (2017-2028)
Figure 70. Latin America Liquid Embolic Agent Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Liquid Embolic Agent Sales Share by Country (2017-2028)
Figure 72. Latin America Liquid Embolic Agent Revenue Share by Country (2017-2028)
Figure 73. Mexico Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Liquid Embolic Agent Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Liquid Embolic Agent Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Liquid Embolic Agent Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Liquid Embolic Agent Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Liquid Embolic Agent Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Liquid Embolic Agent Revenue Share by Country (2017-2028)
Figure 83. Turkey Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Liquid Embolic Agent Revenue (2017-2028) & (US$ Million)
Figure 86. Liquid Embolic Agent Value Chain
Figure 87. Liquid Embolic Agent Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

以下、関連資料のご紹介

頸動脈塞栓保護デバイスのグローバル市場インサイト・予測（～2028年）

Global Carotid Embolic Protection Device Market Insights, Forecast to 2028
QY2207C3661 2022年7月11日 96Pages
新型コロナウイルス感染症のパンデミックにより、世界の頸動脈塞栓保護デバイスの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に頸動脈塞栓保護...

TAVR用脳塞栓保護装置のグローバル市場インサイト・予測（～2028年）

Global Cerebral Embolic Protection Devices for TAVR Market Insights, Forecast to 2028
QY2207C3674 2022年7月11日 92Pages
新型コロナウイルス感染症のパンデミックにより、世界のTAVR用脳塞栓保護装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にTAVR用脳...

頸動脈ステント留置術用塞栓保護装置のグローバル市場インサイト・予測（～2028年）

Global Embolic Protection Devices for Carotid Artery Stenting Market Insights, Forecast to 2028
QY2207C3535 2022年7月11日 88Pages
新型コロナウイルス感染症のパンデミックにより、世界の頸動脈ステント留置術用塞栓保護装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に頸...

世界の液体融雪剤市場予測（～2028年）：ギ酸ナトリウム、塩化カルシウム、酢酸カリウム、その他

Global Liquid Snow Melting Agent Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E1700 2022年5月 100Pages
液体融雪剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。

外部帯電防止剤のグローバル市場インサイト・予測（～2028年）

Global External Antistatic Agent Market Insights, Forecast to 2028
QY2207C0345 2022年7月15日 109Pages
新型コロナウイルス感染症のパンデミックにより、世界の外部帯電防止剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に外部帯電防止剤の世界市...

頸動脈塞栓保護デバイスのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Carotid Embolic Protection Device Market Due to the COVID-19 pandemic, the global Carotid Embolic Protection Device market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the fo…
TAVR用脳塞栓保護装置のグローバル市場インサイト・予測（～2028年） Transcatheter Aortic Valve Replacement (TAVR) is a less invasive procedure that replaces the diseased aortic valve without opening your chest to reach your heart. TAVR can save lives and significantly improve quality of life, but like all medical procedures, it may involve risk. The Cerebral Protect…
頸動脈ステント留置術用塞栓保護装置のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Embolic Protection Devices for Carotid Artery Stenting Market Due to the COVID-19 pandemic, the global Embolic Protection Devices for Carotid Artery Stenting market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ mill…
世界の液体融雪剤市場予測（～2028年）：ギ酸ナトリウム、塩化カルシウム、酢酸カリウム、その他 The Liquid Snow Melting Agent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
WSシリーズ冷却剤のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global WS Series Cooling Agent Market Due to the COVID-19 pandemic, the global WS Series Cooling Agent market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2…